ADMA Biologics Inc — Statistiche Finanziarie Trimestrali (NASDAQ:ADMA) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 50.22 M-19.68 M21.14 M13.29 M35.64 M 50.4 M Flussi di cassa derivanti dalle attività di investimento -2.75 M-4.72 M-2.53 M-14.37 M-276 K -21.89 M Liquidità derivante dalle attività di finanziamento -31.03 M-7.13 M48 K-27.82 M-9.12 M -44.02 M Liquidità libera 47.47 M-24.39 M18.61 M-1.07 M34.36 M 27.5 M

Notizie

ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)